Breaking News
DermNexus 2026 Day 1 Recap: Emerging Therapies and Clinical Insights
The session then transitioned to nonsteroidal topical treatments, including JAK inhibitors, phosphodiesterase 4 (PDE4) inhibitors, and aryl hydrocarbon receptor (AhR)…